Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas
暂无分享,去创建一个
R. Advani | S. Montoto | M. Federico | A. Nagler | S. Horwitz | Y. Ko | W. Kim | M. Cabrera | L. Marcheselli | M. Spina | F. Foss | A. Moskowitz | M. Civallero | M. Bellei | Emanuela A Pesce | C. Chiattone | I. Biasoli | I. Dlouhy | M. Cesaretti
[1] M. Lunning,et al. Hepatosplenic γ-δ T-Cell Lymphoma: Who Is on Your Speed Dial? , 2019, Journal of oncology practice.
[2] R. Advani,et al. The role of autologous stem cell transplantation in patients with nodal peripheral T‐cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study , 2019, Cancer.
[3] Lohith Gowda,et al. Hepatosplenic T-Cell Lymphomas. , 2018, Cancer treatment and research.
[4] L. Medeiros,et al. Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors. , 2018, Human pathology.
[5] R. Advani,et al. Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[6] J. Vose,et al. The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project , 2015, Current Hematologic Malignancy Reports.
[7] L. Wilson,et al. Hematopoietic stem cell transplantation for primary cutaneous γδ T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma. , 2015, Journal of the American Academy of Dermatology.
[8] Marco Foppoli,et al. Gamma‐delta t‐cell lymphomas , 2015, European journal of haematology.
[9] M. Grossbard,et al. Hepatosplenic γδ T-cell lymphoma: an overview. , 2013, Clinical lymphoma, myeloma & leukemia.
[10] A. Lennard,et al. Enteropathy-Associated T-Cell Lymphoma: Epidemiology, Clinical Features, and Current Treatment Strategies , 2011, Current hematologic malignancy reports.
[11] S. Proctor,et al. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. , 2010, Blood.
[12] D. Weisenburger,et al. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] S. Steinberg,et al. Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. , 2003, Blood.
[14] E. Jaffe. Hepatosplenic gamma delta T cell lymphoma , 1999 .